XML 48 R35.htm IDEA: XBRL DOCUMENT v3.23.3
Share-Based Awards (Tables)
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Summary of Option Award Activity
The following table summarizes option award activity for the nine months ended September 30, 2023:
Number
of Shares
Subject to
Existing
Options (in thousands)
Weighted-
Average
Exercise
Price Per
Share
Weighted-
Average
Remaining
Contractual
Life (Years)
Aggregate
Intrinsic
Value
(in millions)
Outstanding at January 1, 202328,598 $44.90 7.1$15 
Granted6,890 42.63 
Exercised(1,454)38.84 
Forfeited or cancelled(892)48.28 
Outstanding at September 30, 202333,142 44.60 7.0173 
Vested and exercisable at September 30, 202319,802 44.96 5.8113 
Fair Value of Options Granted, Estimated at Date of Grant Using Black Scholes Merton Option Pricing Model
The following assumptions were used to determine the fair value of option awards granted for the periods presented:
 Three Months Ended
September 30,
Nine Months Ended
September 30,
 2023202220232022
Expected volatility62%61%
55% - 62%
55% - 61%
Risk-free interest rate4.34%3.38%
3.75% - 4.34%
1.94% - 3.38%
Weighted-average expected life5.3 years5.0 years
5.3 - 6.5 years
4.5 - 6.0 years
Weighted-average fair value of options granted$27.26$18.06$24.06$23.75
Summary of Restricted Stock Units Activity
The following table summarizes activity for restricted stock units for the nine months ended September 30, 2023:
Restricted
Stock Units (in thousands)
Weighted-Average Grant Date Fair Value
Unvested outstanding at January 1, 202310,930 $46.85 
Granted8,191 43.27 
Vested(4,675)45.96 
Forfeited(841)46.58 
Unvested outstanding at September 30, 202313,605 45.01 
Effects of Share Based Compensation in Consolidated Statements of Operations
The following table presents the effects of share-based compensation expense in our condensed consolidated statements of operations during the periods presented (in millions):
 Three Months Ended
September 30,
Nine Months Ended
September 30,
 2023202220232022
Cost of revenue$$$12 $12 
Sales and marketing18 21 53 46 
Technology and development42 57 123 123 
General and administrative45 64 154 142 
Impairment and restructuring costs
— — — 
Share-based compensation - continuing operations109 147 342 325 
Share-based compensation - discontinued operations— — 16 
Total share-based compensation$109 $148 $342 $341